Evidence map›Paper›PMID 42525956›Full record

ArticleCancer research2026

Mechanosensors Collaborate to Regulate DNA Damage Repair in Hepatocellular Carcinoma.

Jiajun Li, Ziyu Ren, Jiamei Yao, Yingying Zhao, Ye Xu, Hongmei Yu, Chuxin Huang, Mimi Wang, Fan Yao, Miao Li and 8 more

Abstract read
In one paragraph

Article in Cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Jiajun Li *Liver Cancer Institute, Zhongshan Hospital, Fudan University & Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, PR China.ORCID 0009-0008-8760-1365
Ziyu Ren *Liver Cancer Institute, Zhongshan Hospital, Fudan University & Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, PR China.ORCID 0009-0009-1030-8360
Jiamei Yao *Liver Cancer Institute, Zhongshan Hospital, Fudan University & Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, PR China.ORCID 0000-0002-3958-2357
Yingying ZhaoLiver Cancer Institute, Zhongshan Hospital, Fudan University & Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, PR China.ORCID 0009-0009-9166-9378
Ye XuLiver Cancer Institute, Zhongshan Hospital, Fudan University & Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, PR China.ORCID 0009-0009-9407-5276
Hongmei YuLiver Cancer Institute, Zhongshan Hospital, Fudan University & Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, PR China.ORCID 0009-0006-2936-0941
Chuxin HuangDepartment of Endocrinology, Huashan Hospital, Fudan University, Shanghai, PR China.ORCID 0000-0003-3649-0497
Mimi WangLiver Cancer Institute, Zhongshan Hospital, Fudan University & Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, PR China.ORCID 0000-0002-9727-8943
Fan YaoLiver Cancer Institute, Zhongshan Hospital, Fudan University & Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, PR China.ORCID 0009-0002-8222-6742
Miao LiLiver Cancer Institute, Zhongshan Hospital, Fudan University & Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, PR China.ORCID 0000-0001-7840-7511
Yaohui WangDepartment of Radiology, Shanghai Cancer Center, Fudan University, Shanghai, PR China.ORCID 0009-0004-9306-4368
Dongmei GaoLiver Cancer Institute, Zhongshan Hospital, Fudan University & Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, PR China.ORCID 0000-0003-3442-5704
Yan ZhaoLiver Cancer Institute, Zhongshan Hospital, Fudan University & Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, PR China.ORCID 0009-0003-2348-452X
Binbin LiuLiver Cancer Institute, Zhongshan Hospital, Fudan University & Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, PR China.ORCID 0000-0002-3458-4046
Zhiming WangDepartment of Oncology, Zhongshan Hospital, Fudan University, Shanghai, PR China.ORCID 0000-0002-7605-377X
Yinying DongDepartment of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, PR China.ORCID 0009-0000-3345-4170
Rongxin ChenLiver Cancer Institute, Zhongshan Hospital, Fudan University & Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, PR China.ORCID 0000-0001-8508-516X
Jiefeng CuiLiver Cancer Institute, Zhongshan Hospital, Fudan University & Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, PR China.ORCID 0000-0001-6996-720X

Funding

National Natural Science Foundation of China (NSFC) 82473492
6 · The paper itself

Abstract

Increased matrix stiffness is a biomechanical feature of hepatocellular carcinoma (HCC) that functions as an important promoting factor driving tumor progression. Characterization of the mechanosensors and the underlying downstream mechanisms driving HCC could help identify potential treatment strategies. In this study, we developed a standard procedure for screening and identifying mechanosensors, revealing two HCC mechanosensors, SDC4 and PKD2. These two mechanosensory pathways collaboratively mediated matrix stiffness-promoted DNA damage repair (DDR). Specifically, SDC4 and PKD2 modulated matrix stiffness-increased BANF1 nuclear translocation by increasing protein phosphatase 2A assembly and activity. Subsequently, nuclear BANF1 boosted the formation of the MRE11-RAD50-NBS1 complex and phosphorylation of its downstream effectors to enhance DDR. These findings not only expand the theoretical understanding of matrix stiffness-regulated DDR but also offer a screening/identification approach for mechanosensors in cancer. SIGNIFICANCE: Matrix stiffness enhances DNA repair via dual pathways in hepatocellular carcinoma, suggesting that targeting mechanosensory cross-talk could be a potential strategy to overcome cytotoxic drug resistance.

Indexed as

Carcinoma, HepatocellularDNA DamageDNA RepairLiver NeoplasmsMechanotransduction, CellularCell Cycle ProteinsCell Line, TumorDNA-Binding ProteinsHumansMRE11 Homologue ProteinNuclear ProteinsPhosphorylationProtein Phosphatase 2Cell Cycle ProteinsDNA-Binding ProteinsMRE11 Homologue ProteinMRE11 protein, humanNBN protein, humanNuclear ProteinsProtein Phosphatase 2

Identifiers

PMID42525956
PMCPMC13669727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.